Cargando…

Meta-Analysis Comparing Potent Oral P2Y(12) Inhibitors versus Clopidogrel in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

BACKGROUND: In patients with atrial fibrillation (AF) receiving percutaneous coronary intervention (PCI), current guidelines recommend against combining potent oral P2Y(12) inhibitors (i.e. ticagrelor or prasugrel) with oral anticoagulant (OAC) therapy, but the evidence is limited. OBJECTIVE: The ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casula, Matteo, Fortuni, Federico, Ferlini, Marco, Fabris, Francesca, Oltrona Visconti, Luigi, Leonardi, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956939/ https://www.ncbi.nlm.nih.gov/pubmed/32895853 http://dx.doi.org/10.1007/s40256-020-00436-8

Ejemplares similares

Atrial fibrillation in advanced renal failure: are there alternative solutions to warfarin-dicumarol?
por: Rossini, Roberta, et al.
Publicado: (2021)

Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock
por: Somaschini, Alberto, et al.
Publicado: (2023)

Acute coronary syndromes during the first and the second wave of COVID-19()
por: Ferlini, Marco, et al.
Publicado: (2022)

Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Gjermeni, Diona, et al.
Publicado: (2022)

Risk of ischaemic and haemorrhagic stroke in Chinese undergoing percutaneous coronary intervention treated with potent P2Y12 inhibitor versus clopidogrel
por: Ng, Andrew Kei-Yan, et al.
Publicado: (2022)

Dual Antithrombotic Therapy with Clopidogrel and Novel Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Real-world Study
por: Kebernik, Julia, et al.
Publicado: (2018)

Modern role for clopidogrel in management of atrial fibrillation and stroke reduction
por: Maegdefessel, Lars, et al.
Publicado: (2010)

Management of Atrial Fibrillation in Patients Undergoing Percutaneous Coronary Intervention
por: Mirra, M, et al.
Publicado: (2014)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
por: YANG, Bin, et al.
Publicado: (2018)

Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
por: Kwak, Soongu, et al.
Publicado: (2019)

Incidence of Ventricular Arrhythmias and 1‐Year Predictors of Mortality in Patients Treated With Implantable Cardioverter‐Defibrillator Undergoing Generator Replacement
por: Demarchi, Andrea, et al.
Publicado: (2021)

Clinical governance programme in patients with acute coronary syndrome: design and methodology of a quality improvement initiative
por: Leonardi, Sergio, et al.
Publicado: (2020)

Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention
por: Lianos, Ioannis, et al.
Publicado: (2022)

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Norgard, Nicholas B, et al.
Publicado: (2009)

The Impact of Clopidogrel Resistance on Clinical Outcome of Iranian Patients Undergoing Percutaneous Coronary Intervention
por: Haji Aghajani, Mohammad, et al.
Publicado: (2018)

Comparison of atrial fibrillation predictors in patients with acute coronary syndrome using ticagrelor or clopidogrel
por: ALGÜL, Engin, et al.
Publicado: (2019)

Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Sambola, Antonia, et al.
Publicado: (2016)

Temporal trends in prevalence and outcomes of atrial fibrillation in patients undergoing percutaneous coronary intervention
por: Morita, Yusuke, et al.
Publicado: (2019)

P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Chen, Po-Wei, et al.
Publicado: (2020)

Pharmacodynamic Effect of Cilostazol Plus Standard Clopidogrel Versus Double-Dose Clopidogrel in Patients With Type 2 Diabetes Undergoing Percutaneous Coronary Intervention
por: Jeong, Young-Hoon, et al.
Publicado: (2012)

Clinical outcomes of bivalirudin versus heparin in atrial fibrillation patients undergoing percutaneous left atrial appendage occlusion
por: Zhang, Xiaochun, et al.
Publicado: (2021)

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
por: Krishnamurthy, Arvindra, et al.
Publicado: (2019)

Aspirin in combination with clopidogrel in the treatment of acute myocardial infarction patients undergoing percutaneous coronary intervention
por: Zhang, Xiaoyan, et al.
Publicado: (2019)

Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
por: Zheng, Wei, et al.
Publicado: (2019)

Association of ABCC2 polymorphism with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention
por: Chen, Lida, et al.
Publicado: (2022)

Triple troubles selecting optimal therapy for atrial fibrillation patients undergoing percutaneous coronary interventions
por: Parodi, Guido, et al.
Publicado: (2016)

Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
por: De Luca, Leonardo, et al.
Publicado: (2022)

Acute Coronary Syndromes and SARS-CoV-2 Infection: Results From an Observational Multicenter Registry During the Second Pandemic Spread in Lombardy
por: Ferlini, Marco, et al.
Publicado: (2022)

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
por: Campo, Gianluca, et al.
Publicado: (2010)

Correction: Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
Publicado: (2019)

Association of ABCB1 Gene Polymorphisms and Clopidogrel Responsiveness in Iranian Patients undergoing Percutaneous Coronary Intervention
por: Namazi, Soha, et al.
Publicado: (2020)

Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Jianan, et al.
Publicado: (2021)

Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention – real life assessment
por: Bogacki, Paweł, et al.
Publicado: (2016)

Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention
por: Koziński, Marek, et al.
Publicado: (2020)

Comparative Safety and Efficacy of Eight Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Liang, Bo, et al.
Publicado: (2022)

Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation, Second Thoughts?
por: Wagdi, Philipp, et al.
Publicado: (2012)

Surgical Ablation of Atrial Fibrillation Using Energy Sources
por: Brick, Alexandre Visconti, et al.
Publicado: (2015)

High-Maintenance-Dose Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
por: Chen, Yu, et al.
Publicado: (2013)

Changes of High Sensitivity C-Reactive Protein During Clopidogrel Therapy in Patients Undergoing Percutaneous Coronary Intervention
por: Hajsadeghi, Shokoufeh, et al.
Publicado: (2015)

Comparative study of ticagrelor and clopidogrel in therapeutic effect of acute myocardial infarction patients undergoing percutaneous coronary intervention
por: Yao, Guangtao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2vcmk28k9ktbnu15daf5mma3gj